Prostacyclin (PGI2), thromboxane A2 (TXA2) and prostaglandins, notably E2 (PGE2) play important roles in mediating and controlling normal and diseased arterial homeostasis. Biosynthesis of PGI2 and TXA2 is catalyzed by a series of enzymes acting sequentially: phospholipase A2, prostaglandin H synthase (PGHS) and prostacyclin synthase (PGIS) or thromboxane synthase (TXAS). During the previous and current funding periods, we have made important contributions in cloning PGIS, TXAS, characterizing of PGHS-1 and PGHS-2 gene transcription and kinetics of PGI2 and TXA2 biosynthesis. Biosynthesis of PGI2 and TXA2 is regulated not only by the expression of these enzymes but also by their subcellular localization and compartmentalization. The overall objective of this project is to elucidate the mechanisms by which the biosynthesis of these vasoactive prostanoids is regulated and to develop new therapeutic strategies for gene transfer. We wish to test the following hypotheses: (1) constitutively augmented and preferential synthesis of PGI2; and (3) co-localization and geographical coupling of PGHS-1 or -2 with PGIS and TXAS influences PGI2 and TXA2 biosynthesis. To test these inter-related hypotheses, we propose the following four specific aims: (1) characterization of transcriptional activation of PGHS-1 gene; (2) regulation of PGIS expression in human endothelial cells; (3) functional linkage of over-expressed PGIS to isoforms of PGHS in prostacyclin synthesis; and (4) colocalization and geographical coupling of PGIS or TXAS with PGHS-1 or PGHS-2. Results from these experiments will provide new fundamental knowledge on prostanoid biosynthesis and will have valuable impact on developing new strategies for gene therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS023327-17
Application #
6565210
Study Section
Project Start
2002-02-01
Project End
2003-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
17
Fiscal Year
2002
Total Cost
$207,281
Indirect Cost
City
Houston
State
TX
Country
United States
Zip Code
77225
Chen, Pei-Feng; Wu, Kenneth K (2009) Two synthetic peptides corresponding to the proximal heme-binding domain and CD1 domain of human endothelial nitric-oxide synthase inhibit the oxygenase activity by interacting with CaM. Arch Biochem Biophys 486:132-40
Wu, Jui-Sheng; Cheung, Wai-Mui; Tsai, Yau-Sheng et al. (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119:1124-34
Liou, Jun-Yang; Ellent, David P; Lee, Sang et al. (2007) Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells 25:1096-103
Liou, Jun-Yang; Lee, Sang; Ghelani, Dipak et al. (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481-7
Cieslik, Katarzyna A; Deng, Wu-Guo; Wu, Kenneth K (2006) Essential role of C-Rel in nitric-oxide synthase-2 transcriptional activation: time-dependent control by salicylate. Mol Pharmacol 70:2004-14
Deng, Wu-Guo; Tang, Shao-Tzu; Tseng, Hui-Ping et al. (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108:518-24
Wu, Kenneth K (2006) Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol Biol 338:281-90
Lin, Teng-Nan; Cheung, Wai-Mui; Wu, Jui-Sheng et al. (2006) 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26:481-7
Wu, Kenneth K (2006) Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb Haemost 96:417-22
Liou, Jun-Yang; Aleksic, Nena; Chen, Shu-Fen et al. (2005) Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res 306:75-84

Showing the most recent 10 out of 63 publications